Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 94

1.

MicroRNA-126-mediated control of cell fate in B-cell myeloid progenitors as a potential alternative to transcriptional factors.

Okuyama K, Ikawa T, Gentner B, Hozumi K, Harnprasopwat R, Lu J, Yamashita R, Ha D, Toyoshima T, Chanda B, Kawamata T, Yokoyama K, Wang S, Ando K, Lodish HF, Tojo A, Kawamoto H, Kotani A.

Proc Natl Acad Sci U S A. 2013 Aug 13;110(33):13410-5. doi: 10.1073/pnas.1220710110. Epub 2013 Jul 26.

2.

Regulation of the MIR155 host gene in physiological and pathological processes.

Elton TS, Selemon H, Elton SM, Parinandi NL.

Gene. 2013 Dec 10;532(1):1-12. doi: 10.1016/j.gene.2012.12.009. Epub 2012 Dec 14. Review.

PMID:
23246696
3.

E2A Antagonizes PU.1 Activity through Inhibition of DNA Binding.

Rogers JH, Owens KS, Kurkewich J, Klopfenstein N, Iyer SR, Simon MC, Dahl R.

Biomed Res Int. 2016;2016:3983686. doi: 10.1155/2016/3983686. Epub 2016 Jan 28.

4.

The regulatory network of B-cell differentiation: a focused view of early B-cell factor 1 function.

Boller S, Grosschedl R.

Immunol Rev. 2014 Sep;261(1):102-15. doi: 10.1111/imr.12206. Review.

5.

Establishment and maintenance of B cell identity.

Grosschedl R.

Cold Spring Harb Symp Quant Biol. 2013;78:23-30. doi: 10.1101/sqb.2013.78.020057. Epub 2014 Apr 14.

PMID:
24733381
6.

Transcriptional fine-tuning of microRNA-223 levels directs lineage choice of human hematopoietic progenitors.

Vian L, Di Carlo M, Pelosi E, Fazi F, Santoro S, Cerio AM, Boe A, Rotilio V, Billi M, Racanicchi S, Testa U, Grignani F, Nervi C.

Cell Death Differ. 2014 Feb;21(2):290-301. doi: 10.1038/cdd.2013.145. Epub 2013 Oct 18.

7.

MIR-23A microRNA cluster inhibits B-cell development.

Kong KY, Owens KS, Rogers JH, Mullenix J, Velu CS, Grimes HL, Dahl R.

Exp Hematol. 2010 Aug;38(8):629-640.e1. doi: 10.1016/j.exphem.2010.04.004. Epub 2010 May 5.

8.

MEF2C and EBF1 Co-regulate B Cell-Specific Transcription.

Kong NR, Davis M, Chai L, Winoto A, Tjian R.

PLoS Genet. 2016 Feb 22;12(2):e1005845. doi: 10.1371/journal.pgen.1005845. eCollection 2016 Feb.

9.

Transcriptional repression of Gata3 is essential for early B cell commitment.

Banerjee A, Northrup D, Boukarabila H, Jacobsen SE, Allman D.

Immunity. 2013 May 23;38(5):930-42. doi: 10.1016/j.immuni.2013.01.014. Epub 2013 May 16.

10.

Ebf1-mediated down-regulation of Id2 and Id3 is essential for specification of the B cell lineage.

Thal MA, Carvalho TL, He T, Kim HG, Gao H, Hagman J, Klug CA.

Proc Natl Acad Sci U S A. 2009 Jan 13;106(2):552-7. doi: 10.1073/pnas.0802550106. Epub 2009 Jan 2.

11.

Compound haploinsufficiencies of Ebf1 and Runx1 genes impede B cell lineage progression.

Lukin K, Fields S, Lopez D, Cherrier M, Ternyak K, Ramírez J, Feeney AJ, Hagman J.

Proc Natl Acad Sci U S A. 2010 Apr 27;107(17):7869-74. doi: 10.1073/pnas.1003525107. Epub 2010 Apr 12.

12.

Zinc finger protein 521 antagonizes early B-cell factor 1 and modulates the B-lymphoid differentiation of primary hematopoietic progenitors.

Mega T, Lupia M, Amodio N, Horton SJ, Mesuraca M, Pelaggi D, Agosti V, Grieco M, Chiarella E, Spina R, Moore MA, Schuringa JJ, Bond HM, Morrone G.

Cell Cycle. 2011 Jul 1;10(13):2129-39. Epub 2011 Jul 1.

PMID:
21593590
14.

A dose-dependent role for EBF1 in repressing non-B-cell-specific genes.

Lukin K, Fields S, Guerrettaz L, Straign D, Rodriguez V, Zandi S, Månsson R, Cambier JC, Sigvardsson M, Hagman J.

Eur J Immunol. 2011 Jun;41(6):1787-93. doi: 10.1002/eji.201041137. Epub 2011 May 9.

15.

Positive intergenic feedback circuitry, involving EBF1 and FOXO1, orchestrates B-cell fate.

Mansson R, Welinder E, Åhsberg J, Lin YC, Benner C, Glass CK, Lucas JS, Sigvardsson M, Murre C.

Proc Natl Acad Sci U S A. 2012 Dec 18;109(51):21028-33. doi: 10.1073/pnas.1211427109. Epub 2012 Dec 4.

16.

Runx1-Cbfβ facilitates early B lymphocyte development by regulating expression of Ebf1.

Seo W, Ikawa T, Kawamoto H, Taniuchi I.

J Exp Med. 2012 Jul 2;209(7):1255-62. doi: 10.1084/jem.20112745. Epub 2012 Jun 4.

17.

MicroRNA-29a and microRNA-142-3p are regulators of myeloid differentiation and acute myeloid leukemia.

Wang XS, Gong JN, Yu J, Wang F, Zhang XH, Yin XL, Tan ZQ, Luo ZM, Yang GH, Shen C, Zhang JW.

Blood. 2012 May 24;119(21):4992-5004. doi: 10.1182/blood-2011-10-385716. Epub 2012 Apr 4.

18.

Pioneering Activity of the C-Terminal Domain of EBF1 Shapes the Chromatin Landscape for B Cell Programming.

Boller S, Ramamoorthy S, Akbas D, Nechanitzky R, Burger L, Murr R, Schübeler D, Grosschedl R.

Immunity. 2016 Mar 15;44(3):527-41. doi: 10.1016/j.immuni.2016.02.021.

19.

miR-9 is an essential oncogenic microRNA specifically overexpressed in mixed lineage leukemia-rearranged leukemia.

Chen P, Price C, Li Z, Li Y, Cao D, Wiley A, He C, Gurbuxani S, Kunjamma RB, Huang H, Jiang X, Arnovitz S, Xu M, Hong GM, Elkahloun AG, Neilly MB, Wunderlich M, Larson RA, Le Beau MM, Mulloy JC, Liu PP, Rowley JD, Chen J.

Proc Natl Acad Sci U S A. 2013 Jul 9;110(28):11511-6. doi: 10.1073/pnas.1310144110. Epub 2013 Jun 24.

20.

In Vivo Deletion of the Cebpa +37 kb Enhancer Markedly Reduces Cebpa mRNA in Myeloid Progenitors but Not in Non-Hematopoietic Tissues to Impair Granulopoiesis.

Guo H, Cooper S, Friedman AD.

PLoS One. 2016 Mar 3;11(3):e0150809. doi: 10.1371/journal.pone.0150809. eCollection 2016.

Supplemental Content

Support Center